Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New supplement aims to ease menstrual cramps in clinical trial

NCT ID NCT07529561

First seen Apr 25, 2026 · Last updated May 21, 2026 · Updated 4 times

Summary

This study tests whether a daily supplement, CL25216, can reduce pain and improve hormonal balance in women with painful periods (primary dysmenorrhea). Eighty healthy women aged 25-40 with moderate to severe cramps will take either the supplement or a placebo for several months. Researchers will measure changes in pain severity, pain duration, and sexual function using standard questionnaires.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PRIMARY DYSMENORRHEA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • DEC Healthcare Hospital,

    Nellore, Andhra Pradesh, India

    Contact Phone: •••-•••-••••

Conditions

Explore the condition pages connected to this study.